Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000512808 | SCV000231327 | uncertain significance | not provided | 2017-01-10 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000194848 | SCV000249430 | likely benign | not specified | 2019-02-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000512808 | SCV000609319 | uncertain significance | not provided | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079377 | SCV001091768 | likely benign | Cohen syndrome | 2023-12-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372100 | SCV002692677 | likely benign | Inborn genetic diseases | 2018-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001079377 | SCV001461453 | likely benign | Cohen syndrome | 2020-04-15 | no assertion criteria provided | clinical testing |